​

Dianthus Therapeutics Ownership | Who Owns Dianthus Therapeutics?

OverviewForecastRevenueFinancialsChart

Dianthus Therapeutics Ownership Summary

Dianthus Therapeutics is owned by 102.61% institutional investors, 8.07% insiders. Kbc group nv is the largest institutional shareholder, holding 0% of DNTH shares.

DNTH Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockDianthus Therapeutics102.61%8.07%-10.68%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Kbc group nv---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Kbc group nv---

Top Buyers

HolderShares% AssetsChange
Kbc group nv---1.59K

Top Sellers

HolderShares% AssetsChange
Kbc group nv---1.59K

Sold Out

HolderChange
Kbc group nv-1.59K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2024964.35%35,129,79412.00%1021.22%55-2315.00%
Sep 30, 20249224.32%31,364,8085.60%911.22%5517.02%2025.00%
Jun 30, 202474-2.63%29,702,50213.90%860.84%47-25.40%16100.00%
Mar 31, 202476100.00%26,076,848153.39%1016.32%63231.58%814.29%
Dec 31, 20233822.58%10,291,1192.17%402.60%19-36.67%7-

Recent Insider Transactions

DateNameRoleActivityValue
Sep 29, 2023Fairmount Funds Management LLC Buy$336.25K
Sep 26, 2023Fairmount Funds Management LLC Buy$394.50K
Sep 19, 2023Fairmount Funds Management LLC Buy$396.00K
Sep 13, 2023Fairmount Funds Management LLC Buy$110.16K
Sep 12, 2023Fairmount Funds Management LLC Buy$161.52K

Insider Transactions Trends

DateBuySell
2025 Q1--
2024 Q3--
2024 Q2--
2024 Q1--
2023 Q35-

DNTH Ownership FAQ

Who Owns Dianthus Therapeutics?

Dianthus Therapeutics shareholders are primarily institutional investors at 102.61%, followed by 8.07% insiders and -10.68% retail investors. The average institutional ownership in Dianthus Therapeutics's industry, Biotech Stocks , is 68.48%, which Dianthus Therapeutics exceeds.

Does Blackrock own Dianthus Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Dianthus Therapeutics.

Who is Dianthus Therapeutics’s biggest shareholder by percentage of total assets invested?

Kbc group nv is Dianthus Therapeutics’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Dianthus Therapeutics shares, valued at 0$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools